MiRNA Sequencing and Assay Market to Grow with a CAGR of 6.58% through 2030

Surge in research and development activities is expected to drive the Global MiRNA Sequencing and Assay Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “MiRNA Sequencing and Assay Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, the Global MiRNA Sequencing and Assay Market stood at USD 22.76 Billion in 2024 and is anticipated to grow with a CAGR of 6.58% through 2030. MicroRNAs (miRNAs) have emerged as key regulators of gene expression, influencing a wide range of biological processes. These small RNA molecules are integral to various cellular functions, including development, immune responses, and disease pathogenesis. As personalized medicine reshapes healthcare, the role of miRNAs in advancing individualized treatment approaches is becoming increasingly significant. MiRNA sequencing and assays are essential in this paradigm, helping to identify miRNA profiles linked to specific diseases. Through miRNA profiling, researchers and clinicians gain critical insights into the molecular mechanisms underlying different conditions, facilitating the development of tailored therapeutic strategies that consider each patient's unique genetic profile. The growing global burden of chronic diseases, such as cancer and cardiovascular disorders, highlights the urgent need to understand the genetic factors driving disease susceptibility and progression. MiRNAs are central to the pathogenesis of these conditions, making them promising targets for diagnostic and therapeutic applications. By uncovering the complex roles of miRNAs in disease development and progression, researchers aim to identify biomarkers for early diagnosis and prognosis. MiRNA sequencing and assays play a pivotal role in this process, offering valuable data to guide both disease research and clinical decision-making.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global MiRNA Sequencing and Assay Market”

The Global MiRNA Sequencing and Assay Market is segmented into Technology, Application End-use, Workflow, Regional Distribution, And Company. 

Based on Workflow, Sequencing have emerged as the dominant segment in the Global MiRNA Sequencing and Assay Market in 2024. Sequencing plays a pivotal role in miRNA research and analysis, serving as the fundamental process for generating data used to identify and quantify miRNAs. It directly captures the genetic information encoded in miRNAs, positioning sequencing as the core workflow in miRNA studies and assays. The data produced during sequencing forms the foundation for subsequent analyses, including miRNA identification, quantification, and differential expression analysis. The quality, accuracy, and depth of sequencing data are critical factors that significantly impact the reliability and validity of research outcomes. As a result, sequencing is indispensable in miRNA research, driving high market demand. It enables researchers to examine the entire miRNA transcriptome, providing a comprehensive view of miRNA expression within a sample. This thorough analysis is essential for identifying differentially expressed miRNAs and understanding their roles in various biological processes, diseases, and treatments. Sequencing data, therefore, serves as the basis for deeper investigative studies.

Based on Region, Asia Pacific have emerged as the fastest growing region in the Global MiRNA Sequencing and Assay Market in 2024. The availability of cost-effective sequencing solutions and the presence of a large patient pool make Asia Pacific an attractive market for companies to expand their miRNA sequencing and assay offerings. This combination of technological advancements, government support, and healthcare demand has positioned Asia Pacific as the fastest-growing region in the global miRNA sequencing and assay market.

Major companies operating in Global MiRNA Sequencing and Assay Market are:

• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• QIAGEN N.V.
• PerkinElmer, Inc.
• Abcam plc
• New England Biolabs, Inc.
• Takara Bio USA Inc.
• Lexogen GmbH
• Norgen Biotek Corp.
• Maravai LifeSciences Holdings, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Nanomaterials, such as gold nanoparticles, carbon nanotubes, and magnetic nanoparticles, are being integrated into miRNA sequencing platforms and assay kits to improve the detection limits of miRNAs. These materials provide a larger surface area and unique physicochemical properties, allowing for more efficient binding and signal amplification of miRNAs. As a result, researchers are able to detect miRNAs with greater sensitivity, even in trace amounts, which is critical for early disease diagnostics, including cancer and other complex conditions”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Sequencing by Synthesis, Sequencing by Oligonucleotide Ligation and Detection (SOLiD), Nanopore Sequencing, Sanger Sequencing, Single Molecule Real-time (SMRT) Sequencing), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-use (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global MiRNA Sequencing and Assay Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global MiRNA Sequencing and Assay Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com